ライフサイエンスコーパス: ACP

1 ACP and AAFP recommend that clinicians select the treatm

2 ACP declined by 12% in Maori and 21% in Pacific children

3 ACP incorporation into the novel orthodontic cement did

4 ACP mitogenome sequence analyses will facilitate ACP pop

5 ACP recommends that clinicians select between either cog

6 ACP was defined as the ability to enable individuals to

7 ACP's Clinical Guidelines Committee (CGC), in collaborat

8 ACP-501 has an acceptable safety profile after a single

9 ACP-501 was well tolerated, and there were no serious ad

10 ACPs are diagnosed with a bimodal peak of incidence (5-1

11 ACPs are driven by somatic mutations in CTNNB1 (encoding

12 Recommendation 1: ACP and AAFP recommend that clinicians initiate treatmen

13 RECOMMENDATION 1: ACP and AAFP recommend that clinicians treat patients wi

14 Recommendation 1: ACP recommends that clinicians choose corticosteroids, n

15 Recommendation 1: ACP recommends that clinicians offer pharmacologic treat

16 Recommendation 1: ACP recommends that clinicians prescribe metformin to pa

17 equences in cox1 and trnAsn regions with 100 ACPs, SNPs in nad1-nad4-nad5 locus through PCR with 252

18 RECOMMENDATION 1A: ACP suggests that clinicians discuss whether to initiate

19 RECOMMENDATION 1B: ACP suggests that clinicians should reevaluate symptoms

20 RECOMMENDATION 1C: ACP suggests that clinicians consider intramuscular rath

21 Recommendation 2: ACP and AAFP recommend that clinicians consider initiati

22 Recommendation 2: ACP recommends that clinicians consider adding either a

23 Recommendation 2: ACP recommends that clinicians treat osteoporotic women

24 Recommendation 2: ACP recommends that clinicians use low-dose colchicine w

25 RECOMMENDATION 2: ACP suggests that clinicians not initiate testosterone t

26 is guideline serves as an update to the 2012 ACP guideline on the same topic.

27 in nad1-nad4-nad5 locus through PCR with 252 ACP samples.

28 RECOMMENDATION 2A: ACP and AAFP suggest that clinicians treat patients with

29 RECOMMENDATION 2B: ACP and AAFP suggest that clinicians treat patients with

30 Recommendation 3: ACP and AAFP recommend that clinicians consider initiati

31 RECOMMENDATION 3: ACP and AAFP suggest against clinicians treating patient

32 Recommendation 3: ACP recommends against initiating long-term urate-loweri

33 Recommendation 3: ACP recommends that clinicians offer pharmacologic treat

34 Recommendation 4: ACP recommends against bone density monitoring during th

35 Recommendation 4: ACP recommends that clinicians discuss benefits, harms,

36 Recommendation 5: ACP recommends against using menopausal estrogen therapy

37 Recommendation 6: ACP recommends that clinicians should make the decision

38 e randomly assigned (1:1:1) to receive ABCP, ACP, or BCP every three weeks.

39 a clear understanding of what is known about ACP for people living with dementia.

40 Acalabrutinib (ACP-196) is a highly selective, potent Bruton tyrosine k

41 Acalabrutinib (ACP-196) is a more selective, irreversible BTK inhibitor

42 icotine delivery systems in order to achieve ACP's vision for a better U.S. health care system.

43 enic pathways and rewiring acyl-CoA and acyl-ACP (acyl carrier protein) metabolism in Yarrowia lipoly

44 firmed the sensitivity of the bacterial acyl-ACP synthase to these drugs in infected human cells.

45 CT775 accepts both acyl-ACP and acyl-CoA as acyl donors and, 1- or 2-acyl isomer

46 Specifically, acyl-CoA/acyl-ACP processing enzymes were targeted to the cytoplasm, p

47 athways to synthesize alka/enes, either acyl-ACP reductase (Aar) and aldehyde deformylating oxygenase

48 t efficiently converts long chain fatty acyl-ACP/fatty acyl-CoA into hydrocarbon.

49 ntrast, TE2 prefers an engineered human acyl-ACP substrate and readily releases short chain fatty aci

50 We successfully identified acyl-ACP elongation intermediates (3-hydroxyacyl-ACPs and 2,3

51 ferase that catalyzes the conversion of acyl-ACP to acyl-phosphate, which is in turn utilized by the

52 osphate from acyl-acyl carrier protein (acyl-ACP) and is also involved in coordinating phospholipid a

53 two enzymes, acyl-acyl carrier protein (acyl-ACP) reductase (AAR) and aldehyde-deformylating oxygenas

54 pport a gating mechanism that regulates acyl-ACP binding and substrate delivery to the KS active site

55 s were the preferred acyl donors, while acyl-ACP (acyl carrier protein), free fatty acids, or galacto

56 el in which LYR proteins associate with acyl-ACP as a mechanism for fatty acid biosynthesis to coordi

57 and polyunsaturated long-chain (C16:3) acyl-ACPs, indicating both the sensitivity of the method and

58 antitative methods to assess individual acyl-ACPs do not exist.

59 e developed a robust method to quantify acyl-ACPs to the picogram level.

60 xhibited higher antimicrobial activity after ACP treatment than the corresponding control revealing a

61 ulfide-containing alkenylidenecyclopropanes (ACPs) to afford five-membered carbo- and heterocyclic ri

62 a Chinese ACP cluster (CAC) and an American ACP cluster (AAC).

63 Any person involved in the development of an ACP clinical guideline or guidance statement must disclo

64 otoelectron spectroscopy analysis of ABP and ACP confirmed that both samples contain high levels of o

65 current descriptions of lipid metabolism and ACP function are incomplete.

66 h and avert dire environmental outcomes, and ACP believes that physicians can play a role in achievin

67 biosynthesis was reconstituted in vitro, and ACP-bound intermediates were assigned for each reaction

68 In some species of marine bacteria, ACPs are arranged into tandem repeats joined by peptide

69 stal structures of substrate mimetic bearing ACPs in complex with the elongating KSs from Escherichia

70 lly reduced bacterial susceptibility to both ACP treated and untreated CFX.

71 H0) that precedes the canonical helix-bundle ACP topology in both cases.

72 CP) position paper, initiated and written by ACP's Medical Practice and Quality Committee and approve

73 Formation of the canonical ACP-linked intermediate with fluoromalonyl-CoA allows in

74 All results showed the presence of a Chinese ACP cluster (CAC) and an American ACP cluster (AAC).

75 The ACTION Respecting Choices ACP intervention as offered to patients in the intervent

76 In this study, two circular ACP mitogenome sequences from California (mt-CApsy, 15,0

77 cherichia coli FAS AT, FabD, and its cognate ACP, AcpP, to interrogate type II FAS ACP-AT interaction

78 converting the terminal thiol of the E. coli ACP 4'-phosphopantetheine arm into a mixed disulfide wit

79 work, we have engineered the native E. coli ACP into tandem di- and tri-domain constructs joined by

80 l rechargeable orthodontic cement containing ACP was developed with a high bracket-enamel bond streng

81 ubtypes, adamantinomatous craniopharyngioma (ACP) and papillary craniopharyngioma (PCP), differ in ge

82 ng human adamantinomatous craniopharyngioma (ACP), derived from Sox2- cells in a paracrine manner.

83 n tumor, adamantinomatous craniopharyngioma (ACP).

84 t introduced from China based on our current ACP collection but somewhere in America.

85 must recognize multiple chemically distinct ACPs and choreograph a ping-pong mechanism, often in an

86 l-whole-cell Footvax vaccine induced anti-Dn-ACP and anti-Dn-MIP antibodies.

87 presence of two homologous ACP domains in Dn-ACP with potent C-type lysozyme inhibitor function, and

88 roducer of fatty acids, uses a single-domain ACP.

89 pounds show no significant difference during ACP duration.

90 by a paralog that produced the enantiomeric ACP-bound diketide caused no changes in processing rates

91 d the time-dependent inhibition of the enoyl-ACP reductase InhA.

92 ates (3-hydroxyacyl-ACPs and 2,3-trans-enoyl-ACPs) and unexpected medium-chain (C10:1, C14:1) and pol

93 recommendation; moderate-quality evidence.) ACP recommends that clinicians and patients select among

94 mitogenome sequence analyses will facilitate ACP population research.

95 ognate ACP, AcpP, to interrogate type II FAS ACP-AT interactions.

96 roaches reveal key catalytic features of FAS ACP-AT interactions.

97 40 children hospitalized with IPD, 26589 for ACP, and 44545 for OM.

98 -specific attractants and suitable lures for ACP traps, but they do not act synergistically.

99 Sixteen percent of patients found ACP conversations distressing.

100 L. asiaticus"-free ACPs (7.29 +/- 0.15).

101 L. asiaticus"-free ACPs than in infected ACPs (67.13% +/- 2.11% vs. 35.61%

102 cians (ACP) discuss key recommendations from ACP's vision for U.S. health care that can advise how we

103 which resulted in the first gain-of-function ACP with improved interactions with its partner enzymes.

104 The size of these tandem fused ACPs was determined by size exclusion chromatography to

105 The polypeptide linker that connects an H0-ACP motif to the preceding domain must therefore be ~12

106 atics analysis suggests that the extended H0-ACP motif is present in 98% of type I cis-acyltransferas

107 were not different between patients who had ACP conversations and those who received usual care.

108 ly reversible, as confirmed through the holo ACP-dependent transesterification of the released produc

109 We describe the presence of two homologous ACP domains in Dn-ACP with potent C-type lysozyme inhibi

110 high-throughput screen for functional hybrid ACP-KS partnerships as well as the discovery of novel an

111 the identification of the (3 R)-hydroxyacyl-ACP dehydratases, HadAB and HadBC, of Mtb FAS-II complex

112 -ACP elongation intermediates (3-hydroxyacyl-ACPs and 2,3-trans-enoyl-ACPs) and unexpected medium-cha

113 [2-(2)H]-(2R,3S)-2-methyl-3-hydroxypentanoyl-ACP (6a) with redox-active, epimerase-inactive EryKR6 fr

114 ate the X-ray crystal structure of a type II ACP-AT complex.

115 ngstrom structures of a mutant with impaired ACP binding reveal a conformational change, suggesting t

116 Importantly, ACP-to-apatitic crystal transformation occurred signific

117 We used this information to improve ACP compatibility with non-cognate PT domains, which res

118 Lures are much needed for improving ACP trapping systems for monitoring populations and surv

119 thus leading to an important improvement in ACP trap capture at low population densities.

120 erved Asp-Ser-Leu-Asp amino acid sequence in ACPs to which acyl groups attach.

121 L. asiaticus"-free ACPs than in infected ACPs (67.13% +/- 2.11% vs. 35.61% +/- 1.26%).

122 ymph pH was significantly higher in infected ACPs (8.13 +/- 0.21) than in "Ca.

123 The local microenvironments inside ACPs were quantified using microelectrodes.

124 omic disparities in hospitalization for IPD, ACP, and OM.

125 This NFS1-ISD11-ACP (SDA) complex forms the core of the iron-sulfur (Fe-

126 lex, containing two copies of the NFS1-ISD11-ACP-ISCU-FXN hetero-pentamer, delineates the interaction

127 or studies were used to prepare two isolated ACP segments from this system for studies of their inter

128 produce epimerized (2S)-2-methyl-3-ketoacyl-ACP (acyl carrier protein) intermediates.

129 is, as predicted, a (2R)-2-methyl-3-ketoacyl-ACP intermediate, came from a newly developed coupled ke

130 on of C2-epimerized (2S)-2-methyl-3-ketoacyl-ACP intermediates.

131 to give the corresponding 2-methy-3-ketoacyl-ACP products during bacterial polyketide biosynthesis me

132 ulting from decreased activity of 3-ketoacyl-ACP synthase II.

133 ed exclusively (2R)-2-methyl-3-ketopentanoyl-ACP ((2R)-10).

134 The resulting 2-methyl-3-ketopentanoyl-ACP (10) was incubated separately with five (2R)- or (2S

135 corresponding (2R)-2-methyl-3-ketopentanoyl-ACP (7a) product.

136 oduct [2-(2)H]-(2R)-2-methyl-3-ketopentanoyl-ACP (7a), consistent with the proposed epimerase activit

137 chemoenzymatically generated 3-ketopentanoyl-ACP (9) were incubated with SAM and BonMT2 from module 2

138 residue predicted to influence ketosynthase-ACP recognition led to improved turnover.

139 pharmacodynamics of recombinant human LCAT (ACP-501).

140 that methylates the free carboxyl of malonyl-ACP.

141 of MbtB to form covalently salicylated MbtB-ACP.

142 e demonstrate that up to three mitochondrial ACP (mtACP) isoforms support the Arabidopsis (Arabidopsi

143 tracystic chemotherapy is used in monocystic ACP.

144 Ion release and re-release from the novel ACP orthodontic cement indicated favorable release and r

145 In the absence of ACP, the complex is destabilized resulting in a profound

146 Recommendations included the adaptation of ACP based on the readiness of the individual; targeting

147 hobic core of ISD11, explaining the basis of ACP stabilization.

148 nsus process to help develop a definition of ACP and provide recommendations for its application.

149 in oncology and beyond, but a definition of ACP and recommendations concerning its use are lacking.

150 would be useful in industrial development of ACP application for wheat germ stabilization.

151 ed, reviews had to evaluate effectiveness of ACP for people with dementia or report on views and expe

152 mentia or report on views and experiences of ACP from the perspective of people with dementia, carers

153 olicies, methods, and presentation format of ACP's clinical guidelines and guidance statements.

154 -phosphopantetheine-conjugated acyl-group of ACP occupies the hydrophobic core of ISD11, explaining t

155 To test the implementation of ACP in patients with advanced cancer, we conducted a clu

156 entification of small molecule inhibitors of ACP-KS interactions.

157 The mean number of ACP conversations per patient was 1.3.

158 pectroscopy studies, improved performance of ACP is attributed to its lower charge transfer resistanc

159 ble the pooling and comparison of results of ACP studies.

160 This role of ACP depends upon its covalently bound 4'-phosphopantethe

161 y recommended, randomised clinical trials of ACP in patients with advanced cancer are scarce.

162 ild-type ACP, demonstrating the viability of ACP fusion as a method to enhance fatty acid yield in ba

163 Views of ACP for people with dementia can be clustered around six

164 es in the electrophysiological properties of ACPs at different developmental stages.

165 Moreover, the proportion of ACPs activated in response to odors was dependent on the

166 teric influence of reaction intermediates on ACP binding, and vice versa.

167 reviously thought, imposing strict limits on ACP-mediated substrate delivery within and between PKS m

168 resence of P173 with added MMP20, while only ACP particles were seen in the absence of MMP20.

169 ezolizumab plus carboplatin plus paclitaxel (ACP) versus BCP in key patient subgroups.

170 ceeds via Delta(9) desaturation of palmitoyl-ACP followed by elongation of the product.

171 stabilizing an amorphous calcium phosphate (ACP) precursor phase.

172 Particles of amorphous calcium phosphate (ACP) were incorporated into PE and PEHB at 40% filler le

173 ty to stabilize amorphous calcium phosphate (ACP), the first mineral phase formed in developing ename

174 The American College of Physicians (ACP) and American Academy of Family Physicians (AAFP) de

175 ription: The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP

176 The American College of Physicians (ACP) and the Centers for Disease Control and Prevention

177 The American College of Physicians (ACP) Clinical Guidelines Committee (CGC) aims to disclos

178 ription: The American College of Physicians (ACP) developed this guideline to present the evidence an

179 ription: The American College of Physicians (ACP) developed this guideline to present the evidence an

180 ription: The American College of Physicians (ACP) developed this guideline to present the evidence an

181 ription: The American College of Physicians (ACP) developed this guideline to present the evidence an

182 The American College of Physicians (ACP) developed this guideline to provide clinical recomm

183 ers from the American College of Physicians (ACP) discuss key recommendations from ACP's vision for U

184 ition of the American College of Physicians (ACP) Ethics Manual covers emerging issues in medical eth

185 The American College of Physicians (ACP) has long advocated for universal access to high-qua

186 ed care, the American College of Physicians (ACP) is attentive to all voices, including those who spe

187 This American College of Physicians (ACP) position paper, initiated and written by ACP's Medi

188 s paper, the American College of Physicians (ACP) proposes that new policies should be implemented to

189 article, the American College of Physicians (ACP) provides recommendations based on the best availabl

190 In 2018, the American College of Physicians (ACP) published a guideline on HbA1c targets for nonpregn

191 tes the 2008 American College of Physicians (ACP) recommendations on treatment of low bone density an

192 n paper, the American College of Physicians (ACP) recommends that physicians and the broader health c

193 The American College of Physicians (ACP) was one of the first organizations in the United St

194 urces of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assess

195 e encoding a homologue of the known pimeloyl-ACP methyl ester cleavage enzymes suggesting that it enc

196 nthase III-like reaction to produce pimeloyl-ACP with five of the seven pimelate carbon atoms being d

197 Advanced care planning (ACP) has the potential to improve outcomes for people wi

198 Advance care planning (ACP) is increasingly implemented in oncology and beyond,

199 Advance care planning (ACP) supports individuals to define, discuss, and record

200 s work was to study atmospheric cold plasma (ACP) degradation of antibiotics in water and meat efflue

201 er the same time of atmospheric cold plasma (ACP) treatment were 77.50% and 92.52%, respectively.

202 mococcal disease (IPD), all-cause pneumonia (ACP), and otitis media (OM), defined by ICD-10-AM codes,

203 reased and was undetectable </=12 hours post ACP-501 infusion.

204 can provide guidance for clinical practice, ACP policy, and research.

205 As a remediation process, ACP removal of antibiotics in complex wastewater effluen

206 Formation of productive ACP-AT interactions is required for catalysis and specif

207 , LA sampling (via ablation crater profiles [ACP]) and aerosol washout/transfer/ICPMS measurement (vi

208 rovided by amygdala corticofugal projection (ACPs).

209 sory protein ISD11, and acyl-carrier protein ACP.

210 chain attached to the acyl carrier protein (ACP) domain of FASN is unknown.

211 and ligation onto the acyl carrier protein (ACP) domain of MbtB to form covalently salicylated MbtB-

212 Mutation of the acyl carrier protein (ACP) domain of the upstream module in one chimera at a r

213 Acyl carrier protein (ACP) domains act as interaction hubs within modular poly

214 xtensive contacts with acyl carrier protein (ACP) during catalysis.

215 hylation of 3-ketoacyl-acyl carrier protein (ACP) intermediates to give the corresponding 2-methy-3-k

216 Acyl carrier protein (ACP) is a highly conserved cofactor protein that is requ

217 e encoding a beta-keto acyl carrier protein (ACP) reductase (BKR) putatively associated with polyketi

218 ynthetic pathways, the acyl carrier protein (ACP) shuttles substrates to appropriate enzymatic partne

219 M protein (ISD11), and acyl carrier protein (ACP) subunits.

220 by the bacterial acyl-acyl carrier protein (ACP) synthase AasC but inhibitors of the host acyl-CoA s

221 catalyze a 3-ketoacyl-acyl carrier protein (ACP) synthase III-like reaction to produce pimeloyl-ACP

222 nthesis, beta-ketoacyl-acyl carrier protein (ACP) synthases (KS), catalyze this process via a decarbo

223 oxyacyl chain from its acyl carrier protein (ACP) to the 3-OH group of UDP-GlcNAc.

224 , LYR protein (ISD11), acyl-carrier protein (ACP), and the iron-sulfur cluster assembly scaffold prot

225 ne and either cellular acyl carrier protein (ACP)-coupled fatty acids or CoA-aryl/acyl moieties as pr

226 switches largely to an acyl carrier protein (ACP)-independent mode.

227 g our understanding of acyl-carrier protein (ACP)-protein interactions.

228 step to an orthogonal acyl carrier protein (ACP).

229 R protein (ISD11), and acyl carrier protein (ACP).

230 ntly complexed with an acyl carrier protein (ACP).

231 acterial pool of acyl-acyl carrier proteins (ACPs) an acyl chain of a specific length for covalent li

232 Acyl carrier proteins (ACPs) are essential to the production of fatty acids.

233 Acyl carrier proteins (ACPs) are the scaffolds for fatty acid biosynthesis in l

234 ds monomer units onto acyl carrier proteins (ACPs), small, flexible proteins that shuttle covalently

235 g of filaments, actin-crosslinking proteins (ACPs) and motors--confers cell structure and functionali

236 is transmitted by the Asian citrus psyllid (ACP) Diaphorina citri, in a circulative manner.

237 The Asian citrus psyllid (ACP) is a vector of a pathogen associated with greening

238 its insect vector, the Asian citrus psyllid (ACP), and whether these changes were beneficial for the

239 Asian citrus psyllid (ACP, Diaphorina citri Kuwayama) transmits "Candidatus Li

240 At C/10 rate, ACP electrode delivered high specific lithium storage re

241 nses, only antisera to rDn-ACP-QuilA and rDn-ACP-Al(OH)(3) significantly prevented rDn-ACP protein fr

242 Therefore, a vaccine incorporating rDn-ACP in particular could contribute to protection by enab

243 Dn-ACP-Al(OH)(3) significantly prevented rDn-ACP protein from inhibiting lysozyme activity in vitro.

244 tre antibody responses, only antisera to rDn-ACP-QuilA and rDn-ACP-Al(OH)(3) significantly prevented

245 Recommendation: ACP recommends that clinicians use synovial fluid analys

246 ays critical mechanistic roles in regulating ACP-phase transformation and enamel crystal growth, and

247 titative measure of mechanistically relevant ACP-KS interactions.

248 ts in the intervention arm included scripted ACP conversations between patients, family members, and

249 ow back pain, which is covered by a separate ACP guideline that has also been endorsed by AAFP.

250 ingly, we observed that four Delta9 stearoyl-ACP desaturase (SAD)-coding genes (FATTY ACID BIOSYNTHES

251 Such ACPs are likely important to medium-chain lipid producti

252 Lastly, E. coli cultures harboring tandem ACPs produced up to 1.6 times more fatty acids than wild

253 n the readiness of the individual; targeting ACP content as the individual's health condition worsens

254 Thus, it is likely that ACP is not simply an obligate subunit but also exploits

255 We proposed that ACP in California was likely not introduced from China b

256 The results revealed that ACP successfully degraded the studied antibiotics and th

257 eal a conformational change, suggesting that ACP may regulate AftD function.

258 The ACP also advised deintensification of therapy for patien

259 The ACP believes these changes will have a meaningful effect

260 The ACP calls for increased efforts to address urgent public

261 The ACP calls for reform of U.S. payment, delivery, and info

262 The ACP Clinical Guidelines Committee based these recommenda

263 The ACP Clinical Guidelines Committee based these recommenda

264 The ACP plans periodic updates of these recommendations on t

265 The ACP remains committed to improving care for patients thr

266 The ACP's recommendations include increased investment in pr

267 ntiality of the putative active site and the ACP binding for AftD function.

268 In brief, the ACP treatment efficiency was function of the input gas a

269 of detailed policy recommendations from the ACP to external stakeholders (such as payers, government

270 However, the ACP believes that the ethical arguments against legalizi

271 ients in the ABCP group, in 172 (43%) in the ACP group, and in 191 (49%) in the BCP group; 11 (3%) gr

272 d in the ABCP group, as did four (1%) in the ACP group, and nine (2%) in the BCP group.

273 on to individualize HbA1c target levels, the ACP proposed a level between 7% and 8% for most patients

274 The peptide primarily occludes the ACP binding site of LpxA.

275 tein (psiACP), in which the apo state of the ACP is essential for methylation of the growing polyketi

276 ontrolled, yet enigmatic coordination of the ACP with its partner enzymes.

277 erns articulated in this position paper, the ACP does not support legalization of physician-assisted

278 merica, and 11 from Australia) who rated the ACP definitions and its 41 recommendations, agreement fo

279 As a result, the ACP recommended against screening for asymptomatic patie

280 This article summarizes the ACP/Annals COVID-19 Vaccine Forum II held on 16 December

281 ed non-physician facilitators to support the ACP process.

282 Using the ACP grading system, the committee based these recommenda

283 Using the ACP grading system, the committee based these recommenda

284 he evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading

285 They review the data on which the ACP/CDC recommendations are based and discuss the potent

286 elop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and wit

287 This ACP position paper calls for ending discrimination based

288 ients were randomly assigned to ABCP, 402 to ACP, and 400 to BCP.

289 is research to test different approaches to ACP.

290 uantal size and contact number at the AOB-to-ACP synapse.

291 miochemicals as potential lures for trapping ACP.

292 istic features--specifically actin turnover, ACP (un)binding and motor walking--to reveal the nature

293 to 1.6 times more fatty acids than wild-type ACP, demonstrating the viability of ACP fusion as a meth

294 Understanding ACP population diversity is necessary for HLB regulatory

295 onstructs was similar to that of the unfused ACP, indicating a lack of interaction between domains.

296 d 2015 for children <6 years of age, whereas ACP and OM declined by 8% and 25%, respectively.

297 andard deviation]) presenting to the ED with ACP.

298 rvival was 21.4 months (95% CI 13.8-NE) with ACP versus 18.7 months (95% CI 13.4-NE) with BCP in EGFR

299 the specificity in identifying patients with ACP with significant CAD in the ED setting and reduce un

300 No overall survival benefit was seen with ACP versus BCP in patients with sensitising EGFR mutatio

301 However, more studies with ACP samples from around the world are needed.